AHA psychiatric constituency section names 2018 leaders

Jan 10, 2018 - 02:27 PM

Mary Lou Mastro, system CEO for Edward-Elmhurst Health in Naperville, IL, is 2018 council chair of the AHA’s Constituency Section for Psychiatric and Substance Abuse Services. Joseph Miller, vice-president of behavioral health care transformation services for Hackensack Meridian Health and clinical assistant professor in the department of psychiatry at Rutgers University’s Robert Wood Johnson Medical School, Jersey Shore University Medical Center in Neptune, NJ, is chair-elect and will assume the role of chair in 2019. The council works with the AHA to identify ways to define and focus AHA policy, advocacy and member resources to improve the quality, efficiency and delivery of psychiatric and substance abuse services. For more on the constituency section and its 18-member council, see the AHA news release.

Related News Articles

Headline
AHA wins 2 Telly Awards for behavioral health video series
 The AHA has won two Telly Awards for its three-part video series, Voices of Leadership: Breaking Mental Health Stigma. The Telly Awards, a global…
Chairperson's File
Chair File: Hospitals Integrate Behavioral Health Care, Provide Hope and Healing
Behavioral health is a crucial component of overall health and well-being, and we see the need and demand for behavioral health care services increasing for…
Headline
White House announces National Drug Control Strategy
The White House May 4 released its National Drug Control Strategy, which, among other efforts, recommends effective primary prevention programs. The…
Headline
HHS announces action plan on psychiatric ‘overprescribing’
The Department of Health and Human Services yesterday announced an action plan on psychiatric prescribing, including efforts to initiate …
Perspective
Behavioral Health Is Health Care
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
President’s EO speeds research, funding for psychedelic drug treatments
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling…